17735-98-7
Chemical Structure
13Z,16Z-Docosadienoic acid
- CAS No.: 17735-98-7
- Formula:C22H40O2
- Molecular Weight:336.55
IUPAC Name: (13Z,16Z)-docosa-13,16-dienoic acid
InChIKey: HVGRZDASOHMCSK-HZJYTTRNSA-N
SMILES: CCCCC/C=C\C/C=C\CCCCCCCCCCCC(O)=O
Biological Activity: 13Z,16Z-Docosadienoic acid is a GPR120 agonist with bactericidal activity. 13Z,16Z-Docosadienoic acid serves as a potential biomarker for canine mammary tumors. 13Z,16Z-Docosadienoic acid is used in the research of bacterial infections, Lyme disease, Graves' disease and mammary tumors[1][2][3][4][5].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
13Z,16Z-Docosadienoic acid | 99.0% | 13Z,16Z-Docosadienoic acid is a GPR120 agonist with bactericidal activity. 13Z,16Z-Docosadienoic acid serves as a potential biomarker for canine mammary tumors. 13Z,16Z-Docosadienoic acid is used in the research of bacterial infections, Lyme disease, Graves' disease and mammary tumors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Lu X, et al. Postprandial inhibition of gastric ghrelin secretion by long-chain fatty acid through GPR120 in isolated gastric ghrelin cells and mice. Am J Physiol Gastrointest Liver Physiol. 2012;303(3):G367-G376. [Content Brief]
- [2]. Goc A, et al. Anti-borreliae efficacy of selected organic oils and fatty acids. BMC Complement Altern Med. 2019;19(1):40. Published 2019 Feb 4. [Content Brief]
- [3]. Li T, et al. Serum metabolomics reveals systemic metabolic alterations of Graves' disease before and after antithyroid drug treatment. Endocr Connect. 2025;14(6):e250078. Published 2025 Jun 18. [Content Brief]
- [4]. Liu H, et al. Metabolomics Analysis Provides Novel Insights into the Difference in Meat Quality between Different Pig Breeds. Foods. 2023;12(18):3476. Published 2023 Sep 19. [Content Brief]
- [5]. Yu C, et al. Identification of canine mammary tumor-associated metabolites using untargeted metabolomics. Theriogenology. 2023;211:84-96. [Content Brief]
Keywords